Literature DB >> 28808843

Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.

Eun Young Kim1, Woo Seok Byon1, Kwan Ho Lee1, Ji-Sup Yun1, Yong Lai Park1, Chan Heun Park2, In Young Youn3, Seon Hyeong Choi3, Yoon Jung Choi3, Shin Ho Kook4, Sung-Im Do5.   

Abstract

BACKGROUND: The aim of this study was to determine the feasibility of image-guided marker-clip placement in axillary lymph nodes (ALNs) for breast cancer upon initial presentation and to assess the reliability of this method with sentinel lymph node biopsy (SLNB) for axillary restaging after neoadjuvant chemotherapy (NAC).
METHODS: Between June 2015 and August 2016, a marker clip was placed at a clinically positive ALN under ultrasonography (US) guidance before initiation of NAC in 20 patients. Preoperative localization of marker-clipped LNs was performed, and the localized LNs were removed by SLNB. We compared the postoperative results of the marker-clipped LNs, SLNs and ALNs.
RESULTS: Image-guided marker-clip placements and localization of marker-clipped LNs were performed successfully in 20 patients. A total of 24 marker clips were inserted, and 23 marker-clipped LNs were successfully retrieved during surgery (identification rate, 23/24, 95.8%). In the 11 patients with pathologically confirmed metastatic marker-clipped LNs, four became negative after NAC, and seven maintained metastatic residues on the marker-clipped LNs. Three of the seven patients had metastatic residues on the ALNs, and two of the three patients also had negative SLNs. Marker-clipped nodes accurately predicted the axillary nodal status in these two patients compared with SLNs alone.
CONCLUSION: Image-guided marker-clip placement on positive ALNs before NAC and removal with SLNB is technically feasible. This technique can improve the accuracy of the residual disease evaluation on the axilla, especially in patients with negative SLNB results, and can identify candidates for limited axillary surgery after NAC.

Entities:  

Mesh:

Year:  2018        PMID: 28808843     DOI: 10.1007/s00268-017-4171-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer.

Authors:  M E Straver; C E Loo; T Alderliesten; E J T Rutgers; M T F D Vrancken Peeters
Journal:  Br J Surg       Date:  2010-08       Impact factor: 6.939

2.  Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

Authors:  Y Xing; M Foy; D D Cox; H M Kuerer; K K Hunt; J N Cormier
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

3.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

4.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

5.  Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.

Authors:  H M Kuerer; A A Sahin; K K Hunt; L A Newman; T M Breslin; F C Ames; M I Ross; A U Buzdar; G N Hortobagyi; S E Singletary
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

6.  Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.

Authors:  Mila Donker; Marieke E Straver; Jelle Wesseling; Claudette E Loo; Margaret Schot; Caroline A Drukker; Harm van Tinteren; Gabe S Sonke; Emiel J Th Rutgers; Marie-Jeanne T F D Vrancken Peeters
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

7.  Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.

Authors:  Katsutoshi Enokido; Chie Watanabe; Seigo Nakamura; Akiko Ogiya; Tomo Osako; Futoshi Akiyama; Akiyo Yoshimura; Hiroji Iwata; Shinji Ohno; Yasuyuki Kojima; Koichiro Tsugawa; Kazuyoshi Motomura; Naoki Hayashi; Hideko Yamauchi; Nobuaki Sato
Journal:  Clin Breast Cancer       Date:  2016-02-11       Impact factor: 3.225

8.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Authors:  Judy C Boughey; Vera J Suman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Henry M Kuerer; Monet Bowling; Teresa S Flippo-Morton; David R Byrd; David W Ollila; Thomas B Julian; Sarah A McLaughlin; Linda McCall; W Fraser Symmans; Huong T Le-Petross; Bruce G Haffty; Thomas A Buchholz; Heidi Nelson; Kelly K Hunt
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

9.  Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).

Authors:  Judy C Boughey; Karla V Ballman; Huong T Le-Petross; Linda M McCall; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; Eric C Feliberti; Kelly K Hunt
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

10.  Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.

Authors:  Jian-Fei Fu; Hai-Long Chen; Jiao Yang; Cheng-Hao Yi; Shu Zheng
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more
  13 in total

1.  Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy.

Authors:  Naoko Iwamoto; Tomoyuki Aruga; Shinichiro Horiguchi; Chiaki Saita; Mai Onishi; Risa Goto; Toshiyuki Ishiba; Yayoi Honda; Hiromi Miyamoto; Katsumasa Kuroi
Journal:  Surg Today       Date:  2019-07-31       Impact factor: 2.549

Review 2.  Different strategies in marking axillary lymph nodes in breast cancer patients undergoing neoadjuvant medical treatment: a systematic review.

Authors:  Vivian Man; Ava Kwong
Journal:  Breast Cancer Res Treat       Date:  2021-02-21       Impact factor: 4.872

3.  Application of ultrasound-guided placement of markers for locating axillary lymph nodes of breast cancer.

Authors:  Xiaohui Ji; Mengying Wei; Liuyuan Wang; Juanjuan Li; Dongxia Gao; Cuizhi Geng
Journal:  Gland Surg       Date:  2021-11

4.  Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study.

Authors:  Vishnu Prasad Pulappadi; Shashi Paul; Smriti Hari; Ekta Dhamija; Smita Manchanda; Kamal Kataria; Sandeep Mathur; Kalaivani Mani; Ajay Gogia; Svs Deo
Journal:  Br J Radiol       Date:  2021-09-07       Impact factor: 3.039

5.  Surgery after Neoadjuvant Chemotherapy: A Clip-Based Technique to Improve Surgical Outcomes, a Single-Center Experience.

Authors:  Carola Minella; Andrea Villasco; Marta D'Alonzo; Lisa Cellini; Francesca Accomasso; Silvia Actis; Nicoletta Biglia
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

6.  Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial.

Authors:  Jan Žatecký; Otakar Kubala; Oldřich Coufal; Markéta Kepičová; Adéla Faridová; Karel Rauš; Milan Lerch; Matúš Peteja; Radim Brát
Journal:  Breast Care (Basel)       Date:  2020-10-14       Impact factor: 2.268

7.  Best MRI sequences for identifying axillary lymph node markers in patients with metastatic breast cancer: an inter-reader observational study.

Authors:  Naziya Samreen; Asha A Bhatt; Kalie Adler; Shannon Zingula; Katrina N Glazebrook
Journal:  Eur Radiol Exp       Date:  2020-06-12

8.  Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Janine M Simons; Thiemo J A van Nijnatten; Carmen C van der Pol; Ernest J T Luiten; Linetta B Koppert; Marjolein L Smidt
Journal:  Ann Surg       Date:  2019-03       Impact factor: 12.969

9.  Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy.

Authors:  Gunay Gurleyik; Sibel Aydin Aksu; Fügen Aker; Kubra Kaytaz Tekyol; Eda Tanrikulu; Emin Gurleyik
Journal:  Ann Surg Treat Res       Date:  2021-06-01       Impact factor: 1.859

10.  Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).

Authors:  Geok Hoon Lim; Sze Yiun Teo; Mihir Gudi; Ruey Pyng Ng; Jinnie Pang; Yia Swam Tan; Yien Sien Lee; John C Allen; Lester Chee Hao Leong
Journal:  Cancer Med       Date:  2020-01-22       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.